Stratagene, Hycor, Sigma-Aldrich, Procognia, BD Bioscience, PerkinElmer | GenomeWeb

Hycor Acquisition, QPCR Sales Boost Stratagene’s Q3 Revenues

Stratagene on Tuesday reported a 37-percent increase in third-quarter revenues and nearly tripled its quarterly net income.

Stratagene’s revenues increased to $23.1 million for the quarter from $16.9 million in the third quarter of 2003. The company’s Hycor subsidiary, which it acquired in June, was responsible for $5.6 million of the increase in revenues for the quarter, Stratagene said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.